The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Axxcess Wealth Management LLC

Axxcess Wealth Management LLC boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 298.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,211 shares of the medical device company’s stock after acquiring an additional 6,150 shares during the period. Axxcess Wealth Management LLC’s holdings in Cooper Companies were worth $833,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Vanguard Group Inc. raised its position in Cooper Companies by 303.0% in the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after purchasing an additional 17,367,502 shares during the last quarter. Bessemer Group Inc. raised its position in Cooper Companies by 305.2% during the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock worth $203,013,000 after buying an additional 1,507,049 shares during the last quarter. Champlain Investment Partners LLC raised its position in Cooper Companies by 295.3% during the 1st quarter. Champlain Investment Partners LLC now owns 1,741,120 shares of the medical device company’s stock worth $176,654,000 after buying an additional 1,300,620 shares during the last quarter. Bank of New York Mellon Corp raised its position in Cooper Companies by 273.8% during the 1st quarter. Bank of New York Mellon Corp now owns 1,731,194 shares of the medical device company’s stock worth $175,647,000 after buying an additional 1,268,109 shares during the last quarter. Finally, Congress Asset Management Co. MA raised its position in Cooper Companies by 252.4% during the 1st quarter. Congress Asset Management Co. MA now owns 1,263,754 shares of the medical device company’s stock worth $128,220,000 after buying an additional 905,173 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Ratings Changes

COO has been the subject of a number of analyst reports. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, May 31st. Robert W. Baird increased their price target on shares of Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a report on Friday, May 31st. Citigroup increased their price target on shares of Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and increased their price target for the company from $107.00 to $115.00 in a report on Tuesday, July 16th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $115.00 price target on shares of Cooper Companies in a research note on Wednesday, July 3rd. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $111.78.

Cooper Companies Stock Up 0.6 %

NASDAQ:COO traded up $0.53 during mid-day trading on Friday, reaching $93.21. The stock had a trading volume of 1,063,385 shares, compared to its average volume of 1,130,185. The Cooper Companies, Inc. has a fifty-two week low of $75.93 and a fifty-two week high of $104.07. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.14. The business’s 50 day moving average is $91.39 and its 200 day moving average is $94.28. The stock has a market cap of $18.56 billion, a P/E ratio of 54.75, a PEG ratio of 2.28 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.83 by $0.02. The firm had revenue of $942.60 million during the quarter, compared to analysts’ expectations of $948.07 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. Cooper Companies’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the business earned $0.77 earnings per share. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.57 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.